Literature DB >> 22727454

Association between age at onset of psychosis and age at onset of cannabis use in non-affective psychosis.

Juan A Galvez-Buccollini1, Ashley C Proal, Veronica Tomaselli, Melissa Trachtenberg, Cristinel Coconcea, Jinsoo Chun, Theo Manschreck, Jerry Fleming, Lynn E Delisi.   

Abstract

INTRODUCTION: Several studies have associated cannabis use with the development of schizophrenia. However, it has been difficult to disentangle the effects of cannabis from that of other illicit drugs, as previous studies have not evaluated pure cannabis users. To test whether the onset of cannabis use had an effect on the initiation of psychosis, we examined the time relationship between onset of use and onset of psychosis, restricting our analysis to a cohort of individuals who only used cannabis and no other street drugs.
METHODS: Fifty-seven subjects with non-affective psychoses who used cannabis prior to developing a psychosis were interviewed using the Diagnostic Interview for Genetic Studies (DIGS). The Family Interview for Genetic Studies (FIGS) was also used to interview a family informant about psychiatric illness in the patient and the entire family. Multiple linear regression techniques were used to estimate the association between variables.
RESULTS: After adjusting for potential confounding factors such as sex, age, lifetime diagnosis of alcohol abuse or dependence, and family history of schizophrenia, the age at onset of cannabis was significantly associated with age at onset of psychosis (β=0.4, 95% CI=0.1-0.7, p=0.004) and age at first hospitalization (β=0.4, 95% CI=0.1-0.8, p=0.008). The mean time between beginning to use cannabis and onset of psychosis was 7.0±4.3. Age at onset of alcohol use was not associated with age at onset of psychosis or age at first hospitalization.
CONCLUSION: Age at onset of cannabis is directly associated with age at onset of psychosis and age at first hospitalization. These associations remain significant after adjusting for potential confounding factors and are consistent with the hypothesis that cannabis could cause or precipitate the onset of psychosis after a prolonged period of time. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2012        PMID: 22727454      PMCID: PMC3415971          DOI: 10.1016/j.schres.2012.06.007

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  12 in total

1.  Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969: historical cohort study.

Authors:  Stanley Zammit; Peter Allebeck; Sven Andreasson; Ingvar Lundberg; Glyn Lewis
Journal:  BMJ       Date:  2002-11-23

2.  Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism.

Authors:  G Estrada; M Fatjó-Vilas; M J Muñoz; G Pulido; M J Miñano; E Toledo; J M Illa; M Martín; M L Miralles; S Miret; S Campanera; C Bernabeu; M E Navarro; L Fañanás
Journal:  Acta Psychiatr Scand       Date:  2011-01-14       Impact factor: 6.392

3.  Comorbid substance use and age at onset of schizophrenia.

Authors:  Thomas R E Barnes; Stanley H Mutsatsa; Sam B Hutton; Hilary C Watt; Eileen M Joyce
Journal:  Br J Psychiatry       Date:  2006-03       Impact factor: 9.319

4.  Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis.

Authors:  Sara Dragt; Dorien H Nieman; Hiske E Becker; Reinaud van de Fliert; Peter M Dingemans; Lieuwe de Haan; Thérèse A van Amelsvoort; Don H Linszen
Journal:  Can J Psychiatry       Date:  2010-03       Impact factor: 4.356

5.  Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

Authors:  J I Nurnberger; M C Blehar; C A Kaufmann; C York-Cooler; S G Simpson; J Harkavy-Friedman; J B Severe; D Malaspina; T Reich
Journal:  Arch Gen Psychiatry       Date:  1994-11

6.  Cannabis use and age of diagnosis of schizophrenia.

Authors:  Gisela Sugranyes; Itziar Flamarique; Eduard Parellada; Immaculada Baeza; Javier Goti; Emilio Fernandez-Egea; Miquel Bernardo
Journal:  Eur Psychiatry       Date:  2009-03-25       Impact factor: 5.361

7.  Cannabis use and age at onset of schizophrenia.

Authors:  Natalie D Veen; Jean-Paul Selten; Ingeborg van der Tweel; Wilma G Feller; Hans W Hoek; René S Kahn
Journal:  Am J Psychiatry       Date:  2004-03       Impact factor: 18.112

8.  Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients.

Authors:  Michael T Compton; Mary E Kelley; Claire E Ramsay; Makenya Pringle; Sandra M Goulding; Michelle L Esterberg; Tarianna Stewart; Elaine F Walker
Journal:  Am J Psychiatry       Date:  2009-10-01       Impact factor: 18.112

9.  Substance misuse at presentation to an early psychosis program.

Authors:  Sarah Van Mastrigt; Jean Addington; Donald Addington
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2004-01       Impact factor: 4.328

10.  The effect of cannabis use and cognitive reserve on age at onset and psychosis outcomes in first-episode schizophrenia.

Authors:  Verity C Leeson; Isobel Harrison; Maria A Ron; Thomas R E Barnes; Eileen M Joyce
Journal:  Schizophr Bull       Date:  2011-03-09       Impact factor: 9.306

View more
  23 in total

Review 1.  Risks associated with the non-medicinal use of cannabis.

Authors:  Eva Hoch; Udo Bonnet; Rainer Thomasius; Florian Ganzer; Ursula Havemann-Reinecke; Ulrich W Preuss
Journal:  Dtsch Arztebl Int       Date:  2015-04-17       Impact factor: 5.594

2.  Age of Cannabis Use Onset and Adult Drug Abuse Symptoms: A Prospective Study of Common Risk Factors and Indirect Effects.

Authors:  Charlie Rioux; Natalie Castellanos-Ryan; Sophie Parent; Frank Vitaro; Richard Ernest Tremblay; Jean Richard Séguin
Journal:  Can J Psychiatry       Date:  2018-04-22       Impact factor: 4.356

3.  Does Cannabis Cause, Exacerbate or Ameliorate Psychiatric Disorders? An Oversimplified Debate Discussed.

Authors:  Margaret Haney; A Eden Evins
Journal:  Neuropsychopharmacology       Date:  2015-08-19       Impact factor: 7.853

4.  Predictors of a clinical high risk status among individuals with a family history of psychosis.

Authors:  Jacqueline Stowkowy; Jean Addington
Journal:  Schizophr Res       Date:  2013-04-20       Impact factor: 4.939

Review 5.  Marijuana: respiratory tract effects.

Authors:  Kelly P Owen; Mark E Sutter; Timothy E Albertson
Journal:  Clin Rev Allergy Immunol       Date:  2014-02       Impact factor: 8.667

6.  Age at initiation of cannabis use predicts age at onset of psychosis: the 7- to 8-year trend.

Authors:  Nikos C Stefanis; Milan Dragovic; Brian D Power; Assen Jablensky; David Castle; Vera Anne Morgan
Journal:  Schizophr Bull       Date:  2013-01-11       Impact factor: 9.306

Review 7.  The Role of Endocannabinoid Signaling in Cortical Inhibitory Neuron Dysfunction in Schizophrenia.

Authors:  David W Volk; David A Lewis
Journal:  Biol Psychiatry       Date:  2015-06-19       Impact factor: 13.382

Review 8.  Cannabis and development of dual diagnoses: A literature review.

Authors:  Rebecca C Hanna; Jessica M Perez; Subroto Ghose
Journal:  Am J Drug Alcohol Abuse       Date:  2016-09-09       Impact factor: 3.829

9.  Effects of early ketamine exposure on cerebral gray matter volume and functional connectivity.

Authors:  Chia-Chun Hung; Yi-Hsuan Liu; Chu-Chung Huang; Cheng-Ying Chou; Chun-Ming Chen; Jeng-Ren Duann; Chiang-Shan R Li; Tony Szu-Hsien Lee; Ching-Po Lin
Journal:  Sci Rep       Date:  2020-09-23       Impact factor: 4.379

10.  Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia.

Authors:  David W Volk; Stephen M Eggan; Andrew G Horti; Dean F Wong; David A Lewis
Journal:  Schizophr Res       Date:  2014-08-05       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.